|
C4ORF14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.340000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.055800E-01 |
| Normal-vs-Stage2 |
2.885600E-01 |
| Normal-vs-Stage3 |
1.965960E-01 |
| Normal-vs-Stage4 |
7.703900E-02 |
| Stage1-vs-Stage2 |
6.465400E-01 |
| Stage1-vs-Stage3 |
4.873000E-01 |
| Stage1-vs-Stage4 |
1.363770E-01 |
| Stage2-vs-Stage3 |
9.026000E-01 |
| Stage2-vs-Stage4 |
3.355400E-01 |
| Stage3-vs-Stage4 |
3.976400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.017600E-02 |
| Normal-vs-AfricanAmerican |
1.502440E-01 |
| Normal-vs-Asian |
7.385600E-01 |
| Caucasian-vs-AfricanAmerican |
7.652000E-01 |
| Caucasian-vs-Asian |
8.641000E-01 |
| AfricanAmerican-vs-Asian |
9.383200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.192400E-02 |
| Normal-vs-Female |
1.173900E-02 |
| Male-vs-Female |
2.887800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.760200E-01 |
| Normal-vs-Extreme_Weight |
3.484000E-01 |
| Normal-vs-Obese |
3.189800E-02 |
| Normal-vs-Extreme_Obese |
7.887200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.965000E-01 |
| Normal_Weight-vs-Obese |
3.832200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.022600E-01 |
| Extreme_Weight-vs-Obese |
2.437400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.536200E-01 |
| Obese-vs-Extreme_Obese |
5.343000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.526030E-01 |
| Normal-vs-Age(41-60Yrs) |
7.281000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.943810E-01 |
| Normal-vs-Age(81-100Yrs) |
7.952600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.427600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.131800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.959830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.613180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.970790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.724200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.527500E-02 |
| Normal-VS-Type2 PRCC |
3.095800E-02 |
| Normal-VS-KIRP CIMP |
6.913400E-01 |
| Normal-VS-Unclassified PRCC |
5.124100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.714800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.526200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.543600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.248000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.979000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.799230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.794600E-01 |
| Normal-vs-N1 |
1.169780E-01 |
| Normal-vs-N2 |
6.253400E-01 |
| N0-vs-N1 |
2.970600E-01 |
| N0-vs-N2 |
6.240400E-01 |
| N1-vs-N2 |
9.906000E-01 |
|
|
